Add
CLRX to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| CLRX > SEC Filings for CLRX > Form 8-K on 9-Jan-2013 | All Recent SEC Filings |
9-Jan-2013
Regulation FD Disclosure
On January 9, 2013, Thomas R. Mika, President and Chief Executive Officer of CollabRx, Inc. (the "Company"), gave investor presentations on the Company's business at OneMedForum SF 2013 and Biotech Showcase 2013. The slides from these presentations are posted on the Company's website, and are attached hereto as Exhibit 99.1 and shall be deemed furnished with this Current Report.
The information in Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit 99.1, shall not be incorporated by reference into any filing under the Securities Act or the Exchange Act.
Item 9.01. Exhibits.
99.1 CollabRx, Inc. Investor Presentation - January, 2013 Slides.
|
|